Latest Pharma Updates... Sep 06
Brovana® is a long-acting beta-2 adrenergic agonist (beta-2 agonist) indicated for treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), ... Jun 23
... Jun 23
ACTO cements its position as the largest life sciences commercial learning and development platform ... Sep 15
-Advertisements-